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Characteristics No Hand OA
(n ¼ 140)
Percentage of No Hand
OA Group
Hand OA
(n ¼ 72)
Percentage of Hand
OA Group
P-value P-value for
linear Trend
Waist Circumference > 40inches
in men, >35 inches in women
122 87.1% 68 94.4% 0.099
Knee KL grade >¼2 139 99.3% 69 95.8% 0.372
Cigarette Smoking Current 59 42.1% 34 47.2% 0.676
Metabolic Syndrome
2 or more metabolic factors
90 64.3% 55 76.4% 0.073
Metabolic Syndrome
3 or more metabolic factors
29 20.7% 24 33.3% 0.044
Metabolic Syndrome Score 0–1 2 3–4 506129 35.7%43.6%20.7% 173124 23.6%43.1%33.3% 0.073 0.023
BMI (Mean, SD) 29.7 (4.8) 29.2 (3.8) 0.424
Age (mean, SD) 59.75 (8.01) 68.11 (6.63) <0.001
Physical Activity PASE (Mean, SD) 168.63 (86.78) 131.54 (72.54) 0.002
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UK TEMPORAL TRENDS FOR TIME FROM DIAGNOSIS OF HIP/KNEE
OSTEOARTHRITIS TO JOINT REPLACEMENT
D.J. Culliford y,z, A. Judge z,x, D. Prieto-Alhambra z, C. Cooper x,z,
N.K. Arden z,x. yUniv. of Southampton, Southampton, United Kingdom;
zUniv. of Oxford, Oxford, United Kingdom; xMRC Lifecourse
Epidemiology Unit, Southampton, United Kingdom
Purpose: To produce UK population-based estimates of elapsed time
from ﬁrst diagnosis of hip/knee osteoarthritis (OA) to primary sur-
gery for those undergoing total joint replacement (TJR) of the hip
(THR) or knee (TKR). These gender-speciﬁc estimates will compare
results for hip and knee using annual summary statistics over a 20
year period.
Methods: We used data from the General Practice Research Database
(GPRD) containing all the computerised records of 6.25m patients, and
representative of the population of the UK. We collected data on all
THRs (N ¼ 20,739) and TKRs (N ¼ 21,715) performed between 1991 and
2010 which also have a reliable prior diagnosis of site-speciﬁc OA. The
distribution of diagnosis-to-TJR time was skewed so we used a log
transformation before comparisons using t tests. As a sensitivity we
used Mann-Whitney tests on untransformed time-to-TJR. Plots com-
paring median diagnosis-to-TJR time for hip and knee, male and female
and younger and older subjects were produced for the 20-year study
period.
Results: Median diagnosis-to-TJR time was 15.5 months (interquartile
range[IQR] 6.7–41.3) for hip, and 38.3 (IQR: 13.7–96.1) for knee over the
entire study period. Overall, and for each individual calendar year
between 1991 and 2006, the timewas signiﬁcantly less for hips than for
knees (p < 0.0001 for all years) when using log time in t tests. Gender-
speciﬁc tests gave similar results (women: p< 0.0001 for all years, men:
p<0.0001 for 1995 onwards). The same tests, but using Mann-Whitney
on untransformed time-to-TJR, also produced a consistent strength and
direction of association with women p < 0.0001 for all years except
1991 (p ¼ 0.0018) and 1993 (p ¼ 0.0002), and men (p < 0.0001 for 1995
onwards). Median time-to-TJR for men was similar to that for women,
both for hips (women 15.0 months; men 16.3) and knees (women 36.9;
men 40.3). However, we did ﬁnd that for both hips and knees, subjects
aged less than 65 at OA diagnosis had a signiﬁcantly greater time-to-TJR
than those aged 65 or over, but we did not ﬁnd any differences in time-
to-TJR when comparing obese (body mass index >¼ 30) to non-obese
subjects.
Conclusions: Using population-based data, we have described
the temporal proﬁle of the time between diagnosis of hip/knee OA
and subsequent TJR. Limitations include the fact that no data on
disease severity at diagnosis was available. Also we did not
account for other interventions which might delay eventual TJR,
but it is suggested that these factors are unlikely to have a dra-
matic effect on the differences in time-to-TJR between hip and
knee.374
DISJOINTED? ASSESSING THE COMPARABILITY OF HIP
REPLACEMENT REGISTRIES TO IMPROVE THE MONITORING OF
OUTCOMES
S. Lacny y, E. Bohm z, G. Hawker x, J. Powell y, D.A. Marshall y. yUniv. of
Calgary, Calgary, AB, Canada; zUniv. of Manitoba, Winnipeg, MB,
Canada; xUniv. of Toronto, Toronto, ON, Canada
Purpose: Joint replacement surgery is a common treatment for severe
osteoarthritis (OA). The rising prevalence of OA has contributed to
increased volumes of joint replacements being performed worldwide.
With a variety of joint replacement techniques and prostheses available
on the market, evaluating the safety, effectiveness, and quality of joint
replacements has become critical from both clinical and healthcare
system perspectives. Joint replacement registries (JRRs) have become
an important source for monitoring, comparing, and improving joint
replacement outcomes. A main focus of recently developed interna-
tional registry organizations, including the International Society of
Arthroplasty Registers (ISAR) and International Consortium of Ortho-
paedic Registries, has been to encourage collaborations between JRRs to
improve evaluation and better understand variability in joint replace-
ment outcomes. However, differences in deﬁnitions and methods of
analysis and reporting of important outcomes, such as revisions rates
and patient-reported outcome measures (PROMs), limit the ability to
make meaningful comparisons across JRRs. Our objective was to assess
the comparability of JRR data by examining the deﬁnitions, analyses,
and outcomes reported by established hip JRRs.
Methods: To ensure high-quality hip JRRs were included, we identiﬁed
full (national JRRs with over 80% national validated data) or associate
(national JRRs with under 80% national data or no validation processes,
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reports in English. We compared deﬁnitions and reporting of common
outcomes: mean age of patients; primary and revision procedures
speciﬁc to total hip arthroplasty (THA) and hip resurfacing arthroplasty
(HRA); deﬁnitions, coding, analysis, and reporting of revisions; doc-
umentation of reasons for revision; and the type, frequency, and
reporting of PROMs.
Results: Eight of 24 identiﬁed hip JRRs met our inclusion criteria: the
Australian Orthopaedic Association National Joint Replacement Regis-
try, the Canadian Joint Replacement Registry, the National Joint Registry
of England and Wales, the New Zealand Joint Registry, the Norwegian
Arthroplasty Register, the Scottish Arthroplasty Project, the Slovak
Arthroplasty Register, and the Swedish Hip Arthroplasty Register. The
annual number of primary and revision hip replacement procedures
was reported by all JRRs. Six JRRs reported the annual number of pri-
mary procedures speciﬁc to HRAs, while just four JRRs reported the
number of revision HRAs. Seven JRRs reported the mean age of THA
patients, and two JRRs reported the mean age of HRA patients. The
deﬁnition of revision was similar across all JRRs. Various units (hips,
patients and components) and metrics (revision burden, person-time
incidence rates and cumulative percent revised) were used to analyze
and report revisions. Kaplan-Meier survival analysis was used among
six JRRs that provided survivorship curves. Seven JRRs reported reasons
for revision for all types of hip replacements, while only two JRRs
provided reasons for revision for HRAs. Although three JRRs described
the collection of PROMs, only one JRR reported PROMs (EQ-5D, pain and
satisfaction visual analogue scales) in their annual report.
Conclusions: Our review highlights considerable variability in the
collection, analysis, and reporting of surgical and patient-reported
outcomes among eight hip JRRs, which creates challenges when com-
paring outcomes across JRRs. Few JRRs currently collect and report
PROMs, despite increased pressure among policy makers to use PROMs
to assess appropriateness of care. Going forward, JRRs have the
opportunity to collectively incorporate standardized PROMs into reg-
ular data collection and encourage their widespread use, though the
choice of instrument and frequency of data collection, analysis, and
reporting will require careful consideration. The integration of PROMs
along with standardizedmetrics and analysis methods has the potential
to improve the monitoring and comparability of joint replacement
outcomes internationally, and ultimately improve care provided to
patients requiring joint replacement surgery.
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OUTCOMES AFTER TOTAL HIP REPLACEMENT
R. Pinedo-Villanueva y,z, D. Turner x, J.P. Raftery k, C. Cooper z,
N.K. Arden y. yUniv. of Oxford, Oxford, United Kingdom; zMRC Lifecourse
Epidemiology Unit, Southampton, United Kingdom; xUniv. of East Anglia,
Norwich, United Kingdom; kUniv. of Southampton, Southampton, United
Kingdom
Purpose: Total hip replacements (THRs) are known to be highly effec-
tive and cost-effective procedures. Pain, mobility and quality of life
signiﬁcantly improve for most patients after the operation. However,
between 5% and 10% of patients report that they are not satisﬁed with
the results of the operation. We aimed to describe outcomes following
primary THRs in the UK, with special attention to their proportions and
health-related quality of life (HRQL)
Methods: Economic models of THR have typically considered that pri-
mary THRs are followed by immediate revisions, death, or a single
successful surgery outcome. We used a cut-off point of 38 on the post-
operative Oxford Hip Score (OHS) identiﬁed by association with sat-
isfaction to differentiate between patients who performed very well in
pain, mobility and function and were satisﬁed with the operation
(“good” outcomes) and those who performed fairly and were more
likely to be dissatisﬁed (“fair” outcomes) We used data from 68,156
primary THRs reported in the Hospital Episode Statistics (HES) for
England for the three ﬁscal years between 2009 and 2012 successfully
matched to PROMs records and reporting non-missing OHS at six
months after the operation as well as pre and postoperative EQ-5D
scores. We conducted a descriptive analysis of the proportion of “good”
and “fair” outcomes as well as their OHS and EQ-5D scores. The analysis
was performed separately for eight patient subgroups created based on
gender and four different age bands (45–59, 60–69, 70–79, 80 and
above).Results: Of all THRs included, 59% were performed on women. The
largest of the eight patient subgroups was women aged 70 to 79, closely
followed bywomen between 60 and 69 years of age (22% and 20% of the
sample, respectively). Only 4% of the sample were men 80 years of age
or older. Mean age was 68 for men and 69 for women, and primary
diagnosis was OA (“coxarthrosis” on the ICD-10) for 87% of procedures.
Mean preoperative OHS was 18.1 (CI 18.06–18.18), increasing to 38.5 (CI
38.47–38.61) at the postoperative measure, taken six months after the
operation. For all patient subgroups the change in OHS was between 19
and 21 points, with women aged 45 to 59 recording the highest mean
change (21.6) and men 80 years of age or older reporting the smallest
(19.6). HRQL, as measured by the EQ-5D summary index, increased from
0.35 (CI 0.352–0.357) to 0.77 (CI 0.773–0.776) for the entire sample.
Both the youngest and oldest subgroups of women reported the highest
change in health utility with 0.44, whereas the smallest mean change
was 0.39 and experienced by men aged 45 to 59. Dividing patients into
outcome category groups by applying the threshold of 38 to post-
operative OHS generated a group of “good” outcomes with 65% of the
sample, whilst the remaining 35% were assigned to the “fair” outcome
category. The proportion of “good” outcomes varied slightly by patient
subgroup, women reporting 64%, 67%, 59% and 49% as the age band
increased, whilst respective values for menwere 74%, 69%, 60% and 64%.
“Good” outcomes had a mean change in OHS of 24.2 (CI 24.17–24.32),
rising from 19.9 to 44.1, whilst for “fair” outcomes the mean reported
OHS change was 13.4 (CI 13.31–13.55), increasing from 14.9 to 28.3.
Whereas less than 0.1% of “good” outcomes saw their OHS decreased
after the operation, 7.4% of those categorised as “fair” reported a drop in
the OHS. Health utilities also increased more for “good” than for “fair”
outcomes, the former reporting a positive jump of 0.47 (CI 0.470–0.476)
compared to 0.32 (CI 0.319–0.328) by the latter. In average, “good”
outcomes went from 0.42 to 0.89 whilst “fair” outcomes took their
mean preoperative index from 0.24 to 0.57. Finally, a drop in health
utility was reported by 13% of “fair” outcomes and 2% of “good”
outcomes.
Conclusions: THRs are a remarkable procedure generating a signiﬁcant
improvement in pain, mobility and function represented by a mean
change of 20 points in the OHS. Primary THR patients experienced a
monumental boost in their HRQL equivalent to 40% of the distance
between death and perfect health (0.42 change in EQ-5D), which few if
any other health intervention at all has reported before. These results
vary only slightly by gender and age but they do change noticeably if
outcome categories are considered following the operation. THRs pro-
duce 65% of “good” outcomes and 35% of “fair” outcomes, distinguished
not only by the postoperative OHS threshold that created the groups but
also by a better starting point and larger improvement in both OHS and
EQ-5D on the part of “good” compared to “fair” outcomes, although the
vast majority of the latter reported an improvement in both.
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WHAT COULD THE FUTURE HOLD? SIMULATING THE DEMAND FOR
OSTEOARTHRITIS (OA) CARE IN ALBERTA TO PLAN A SUSTAINABLE
OA CARE SYSTEM
D.A. Marshall y, S. Vanderby z, C. Frank x, T. Wasylak k, D. Mosher y,
T. Noseworthy k, C. Maxwell{, K.V. MacDonald y, M. Carter#. yUniv. of
Calgary, Calgary, AB, Canada; zUniv. of Saskatchewan, Saskatoon, SK,
Canada; xAlberta Innovates Hlth. Solutions, Calgary, AB, Canada;
kAlberta Hlth. Services, Calgary, AB, Canada; {Univ. of Waterloo,
Waterloo, ON, Canada; #Univ. of Toronto, Toronto, ON, Canada
Purpose: The prevalence of osteoarthritis (OA) is increasing with the
aging population; correspondingly, the demand for OA care, including
hip and knee replacement surgery, is increasing. Simultaneously,
combined with patients seeking surgery at younger ages and more
revision surgeries, there is an increasing burden on the healthcare
system. In systems with limited surgical capacity, such as Canada’s, this
is raising concerns about lengthy surgical wait times. Policy makers are
being called upon to identify means of managing these anticipated
future demands in order to meet benchmark targets in a way that is
sustainable. Unfortunately, policy makers currently lack reliable and
validated tools that enable them to explore the short- and long-term
effects of various policy options. In close collaboration with health
administrators, clinicians, and the government, we developed and
validated a quantitative decision support tool to address this need. The
resulting tool can help policy makers explore the effects of various
